Skip to content

The Clinical and Hemodynamic Course of Cardiogenic Shocks Hospitalized in Critical Care

The Clinical and Hemodynamic Course of Cardiogenic Shocks Hospitalized in Critical Care

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05752383
Acronym
HEMOCARD
Enrollment
500
Registered
2023-03-02
Start date
2023-01-24
Completion date
2029-01-31
Last updated
2023-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiogenic Shock

Keywords

Cardiogenic Shock, vaso-inotropic score

Brief summary

Cardiogenic shock is a frequent reason for hospitalization in critical care units, with high mortality (50%). Several French registries have been created to improve knowledge of the prognostic factors of cardiogenic shock. In recent years, temporary mechanical circulatory support has become more important in cardiogenic shock. The monitoring of catecholamines is also performed with a global score: the vaso-inotropic score. The purpose of our study is to consider using these new data and techniques to create a cohort of cardiogenic shock within our critical care unit. This observational study is based on clinical, biological, and hemodynamic data recorded during the ICU stay of patients for cardiogenic shock. The primary endpoint is the relationship between the hemodynamic evolution of cardiogenic shock and in-hospital mortality.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients hospitalized in ICU for cardiogenic shock * Patient with cardiogenic shock as defined by the FRENSCHOCK2 study criteria

Exclusion criteria

* Patient with cardiogenic shock in the context of septic shock and hemorrhagic shock

Design outcomes

Primary

MeasureTime frameDescription
Percentage of in-hospital mortality after cardiogenic shock5 years
Vaso-inotropic score after cardiogenic shock5 yearsvasoactive-inotropic score (VIS) Maximal VIS (VISmax) is calculated using the highest doses of vasoactive and inotropic medications administered. VISmax categories: 0-5, \>5-15, \>15-30, \>30-45, and \>45 points.

Countries

France

Contacts

Primary ContactChristophe Beyls, MD
beyls.christophe@chu-amiens.fr03 22 08 78 66

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026